Association Between Individual Clotting Factor Level Monitoring and the Risk of Bleeding Whilst Physical Active Conditions

UnknownOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

December 1, 2022

Study Completion Date

December 30, 2022

Conditions
Hemophilia A
Interventions
OTHER

Observation of the association between clotting factor level and risk of bleeding whilst physical activity

"The participants of this study will be monitored for a period of twelve months regarding individual clotting factor level, bleeding episodes as well as type and intensity of physical activity. By doing so, bleeding events, factor consumption as well as the course of the individual factor clotting factor level will be documented via the mobile application myPKFiT. This individual factor treatment regime will be compared with the retrospective treatment outcome in the last twelve months before the first study visit."

Trial Locations (1)

42117

RECRUITING

Department of Sports Medicine, University of Wuppertal, Wuppertal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

collaborator

University of Bonn

OTHER

lead

Prof. Dr. Dr. Thomas Hilberg

OTHER